Last reviewed · How we verify
NCT05724758
Patient Reported Outcomes After Oncoplastic Breast Conserving Surgery
trial testing Breast-conserving surgery in Breast Cancer Stage I in 100 participants. Status unknown.
1 September 2023
Quick facts
| Lead sponsor | Brust-Zentrum AG |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 100 |
| Start date | 1 March 2023 |
| Primary completion | 1 September 2023 |
| Estimated completion | 1 September 2024 |
Drugs / interventions tested
- Breast-conserving surgery
Conditions studied
- Breast Cancer Stage I — all drugs for Breast Cancer Stage I →
- Breast Cancer Stage II — all drugs for Breast Cancer Stage II →
- Breast Cancer in Situ — all drugs for Breast Cancer in Situ →
Sponsor
Brust-Zentrum AG
Who can join
18 and older, female only, with Breast Cancer Stage I or Breast Cancer Stage II. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this study is to assess patient satisfaction after oncoplastic breast conserving surgery. With the help of a breast-questionnaire the patient satisfaction will be assessed before the surgery and 4 weeks, 6 months and 1 year after the operation. The main question it aims to answer are: Does breast conserving surgery improve quality of life. type of study: cohort study, observational OCBS = oncoplastic breast conserving surgery BCT = breast conserving therapy DCIS = ductal carcinoma in situ participant population/health conditions * Patients with newly diagnosed breast cancer, that can be treated breast conserving * the participants have to be at least 18 years old Participants will fill out a questionnaire pre surgery, 4 weeks, 6 months and 1 year after the surgery. The individual questionnaires will be compared.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05724758
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Breast-conserving surgery
Trials testing the same drug.
- NCT07483996 — Cryoablation Versus Lumpectomy in Early-Stage Breast Cancer · Phase 3 · not yet recruiting
- NCT06425874 — The Impact of Socioeconomic Determinants on the Patient Reported Outcomes in Young Breast Cancer Patients After Breast S · recruiting
- NCT06429644 — Long-term Oncologic Outcome of Breast-conserving Surgery in Breast Cancer Patients With BRCA1/2 Mutations · completed
Other recruiting trials for Breast Cancer Stage I
Currently open trials in the same condition.
- NCT06802172 — Effect of Meal Timing During Cancer Treatment in Patients in Alaska: A Randomized Clinical Trial · NA · recruiting
- NCT07002177 — A Phase Ib/II Study to Evaluate Multiple Combination Therapies of FWD1802 in Patients With ER+/HER2- BC · Phase 1, PHASE2 · recruiting
- NCT06727773 — Memantine and Exercise to Improve Cognitive Function and Modulate Biological Pathways of Cognitive Decline During Chemot · Phase 2 · recruiting
- NCT06476119 — OPTImaL:Optimisation of Treatment for Patients With Low Stage Triple-negative Breast Cancer With High Stromal Tumor-infi · recruiting
- NCT06275126 — Optimizing Surgical Decisions in Young Adults With Breast Cancer · NA · recruiting
Other Brust-Zentrum AG trials
Trials by the same sponsor.
- NCT03530722 — Ex-vivo Performance Evaluation of the Histolog™ Scanner for Human Breast Carcinoma Detection on Fresh Breast Core Biopsi · completed
- NCT03470909 — SKINI - Radicality of Skin-Sparing and Nipple-Sparing Mastectomy · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05724758 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Brust-Zentrum AG
- Last refreshed: 13 February 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05724758.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing